(b)(6).
Prismaflex st100 set c has been temporarily approved for use in the us under emergency use authorization (b)(4) to deliver crrt to treat patients in an acute care environment during the covid-19 pandemic.
A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.
The actual device was not available; however, a photograph of the sample was provided for evaluation.
The visual inspection of the provided picture showed a fluid leak at the level of the male luer lock of a cracked access line.
The cause of the reported issue was design related.
A nonconformance has been opened to address this issue.
Should additional relevant information become available, a supplemental report will be submitted.
|